RU2009114885A - PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID ORAL DRUG FORM FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT - Google Patents
PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID ORAL DRUG FORM FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT Download PDFInfo
- Publication number
- RU2009114885A RU2009114885A RU2009114885/15A RU2009114885A RU2009114885A RU 2009114885 A RU2009114885 A RU 2009114885A RU 2009114885/15 A RU2009114885/15 A RU 2009114885/15A RU 2009114885 A RU2009114885 A RU 2009114885A RU 2009114885 A RU2009114885 A RU 2009114885A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- talc
- shell
- weight
- Prior art date
Links
Abstract
1. Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта, включающая в качестве активного компонента тримебутина малеат и целевые вспомогательные вещества, отличающаяся тем, что она содержит эффективное количество тримебутина малеата и в качестве целевых добавок, взятых в количестве 28,5-56,6% от массы действующего вещества, она содержит лактозу, кремний диоксид коллоидный, тальк, кукурузный крахмал, стеарат магния при следующем соотношении ингредиентов, % от массы действующего вещества: ! Тримебутина малеат 43,40-71,50 Лактоза 37,80-12,90 Кремния диоксид коллоидный 1,70-12,90 Тальк 0,80-2,50 Кукурузный крахмал 13,40-1,10 Стеарат магния 2,60-10,70 ! 2. Фармацевтическая композиция по п.1, отличающаяся тем, что она выполнена в виде твердой лекарственной формы. ! 3. Фармацевтическая композиция по п.2, отличающаяся тем, что она выполнена в виде таблеток, покрытых оболочкой. ! 4. Фармацевтическая композиция по п.3, отличающаяся тем, что оболочка составляет до 5% от массы таблетки без оболочки. ! 5. Фармацевтическая композиция по п.4, отличающаяся тем, что оболочка содержит поливиниловый спирт, тальк, полиэтиленгликоль, титана диоксид, приемлемые красители или готовую смесь марки «Opadry II». 1. A pharmaceutical composition for the treatment of diseases of the gastrointestinal tract, comprising as an active component of trimebutin maleate and target excipients, characterized in that it contains an effective amount of trimebutin maleate and as target additives, taken in an amount of 28.5-56.6 % by weight of the active substance, it contains lactose, colloidal silicon dioxide, talc, corn starch, magnesium stearate in the following ratio of ingredients,% by weight of the active substance:! Trimebutin maleate 43.40-71.50 Lactose 37.80-12.90 Silicon colloidal dioxide 1.70-12.90 Talc 0.80-2.50 Corn starch 13.40-1.10 Magnesium stearate 2.60- 10.70! 2. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of a solid dosage form. ! 3. The pharmaceutical composition according to claim 2, characterized in that it is made in the form of coated tablets. ! 4. The pharmaceutical composition according to claim 3, characterized in that the shell is up to 5% by weight of a tablet without a shell. ! 5. The pharmaceutical composition according to claim 4, characterized in that the shell contains polyvinyl alcohol, talc, polyethylene glycol, titanium dioxide, acceptable colorants or the finished mixture of the brand "Opadry II".
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009114885/15A RU2418576C2 (en) | 2009-04-22 | 2009-04-22 | Pharmaceutical composition in form of hard peroral drug for treatment of gastrointestinal tract diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009114885/15A RU2418576C2 (en) | 2009-04-22 | 2009-04-22 | Pharmaceutical composition in form of hard peroral drug for treatment of gastrointestinal tract diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2009114885A true RU2009114885A (en) | 2010-10-27 |
RU2418576C2 RU2418576C2 (en) | 2011-05-20 |
Family
ID=44041905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2009114885/15A RU2418576C2 (en) | 2009-04-22 | 2009-04-22 | Pharmaceutical composition in form of hard peroral drug for treatment of gastrointestinal tract diseases |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2418576C2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2536254C1 (en) * | 2013-11-26 | 2014-12-20 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Retard tablets of trimebutine |
RU2740750C1 (en) * | 2020-03-27 | 2021-01-20 | Аллан Герович Бениашвили | Agent for treating functional gastrointestinal diseases |
-
2009
- 2009-04-22 RU RU2009114885/15A patent/RU2418576C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2418576C2 (en) | 2011-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2273985T3 (en) | Capsule for the prevention of cardiovascular diseases | |
JP2006516570A5 (en) | ||
RU2015151938A (en) | TABLETABLE MEDICINE (4'-TRIFFORMETHYLPHENYL) AMID (Z) -2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID WITH IMPROVED STABILITY | |
RU2014115287A (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH MASKED TASTE AND METHOD FOR PRODUCING IT | |
EP3150201A1 (en) | Composite preparation comprising 5- -reductase inhibitor-containing film coating layer, and method for producing the composite preparation | |
RU2011134964A (en) | PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITAZAR | |
RU2009114885A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID ORAL DRUG FORM FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT | |
RU2013126056A (en) | COMPOSITION FOR TREATMENT OF INVERVATION DISORDERS (OPTIONS) | |
RU2008115582A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | |
RU2006104035A (en) | SOLID MEDICINAL FORM OF DIINDOLYLMETHANE FOR THE TREATMENT OF NEOPLASTIC DISEASES | |
RU2012136190A (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF ARTHROZOARTHRITIS CONTAINING REBAMIPID AS AN ACTIVE INGREDIENT | |
RU2677649C2 (en) | Pharmaceutical compositions of montelucast and levocetirisine | |
US20170151244A1 (en) | Oral pharmaceutical composition of tofacitinib | |
RU2009132616A (en) | PHARMACEUTICAL COMPOSITION OF LONG-TERM ACTION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | |
RU2008147739A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
RU2707286C1 (en) | Pharmaceutical antifungal composition based on a chlorophenylbutanedione derivative and a method for production thereof | |
RU2009101126A (en) | PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC ACTION | |
RU2580303C1 (en) | Composition of pellet drug with proroxanum active ingredient | |
RU2009134909A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
RU2005140982A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF PROLIFERATIVE BREAST DISEASES | |
RU2010134123A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES | |
RU2009134910A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
WO2021053564A1 (en) | Pharmaceutical composition comprising remogliflozin or salt or ester thereof and teneligliptin or salt thereof | |
RU2008113043A (en) | PHARMACEUTICAL COMPOSITION WITH ANTI-MIRACLE ACTION | |
RU2005125959A (en) | SOLID MEDICINAL FORM FOR VAGINAL USE, INCLUDING ITRAKONAZOLE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
QB4A | Licence on use of patent |
Free format text: LICENCE Effective date: 20110805 |
|
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20120926 |
|
QZ41 | Official registration of changes to a registered agreement (patent) |
Free format text: LICENCE FORMERLY AGREED ON 20110805 Effective date: 20130110 |
|
QC41 | Official registration of the termination of the licence agreement or other agreements on the disposal of an exclusive right |
Free format text: LICENCE FORMERLY AGREED ON 20110805 Effective date: 20170629 |
|
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20170731 |
|
QB4A | Licence on use of patent |
Free format text: LICENCE Effective date: 20170802 |
|
QZ41 | Official registration of changes to a registered agreement (patent) |
Free format text: LICENCE FORMERLY AGREED ON 20170802 Effective date: 20180802 |
|
PD4A | Correction of name of patent owner | ||
QZ41 | Official registration of changes to a registered agreement (patent) |
Free format text: LICENCE FORMERLY AGREED ON 20170802 Effective date: 20210630 |